Karabulut S - Search Results

1

Is there any diagnostic value of serum caveolin-1 levels on the determination of pancreatic adenocarcinoma?

Karabulut S, Afsar CU, Paksoy N, Ferhatoglu F, Dogan I, Tastekin D. Karabulut S, et al. J Cancer Res Ther. 2024 Jan 22. doi: 10.4103/jcrt.jcrt_469_23. Online ahead of print. J Cancer Res Ther. 2024. PMID: 38261434 Free article.

2

Clinical significance of coagulation assays in metastatic pancreatic adenocarcinoma.

Tas F, Karabulut S, Bilgin E, Kılıc L, Ciftci R, Duranyildiz D. Tas F, et al. Among authors: karabulut s. J Gastrointest Cancer. 2013 Dec;44(4):404-9. doi: 10.1007/s12029-013-9512-8. J Gastrointest Cancer. 2013. PMID: 23765155

3

Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma.

Tas F, Karabulut S, Bilgin E, Sen F, Yildiz I, Tastekin D, Ciftci R, Duranyildiz D. Tas F, et al. Among authors: karabulut s. Tumour Biol. 2013 Dec;34(6):3529-36. doi: 10.1007/s13277-013-0931-8. Epub 2013 Jun 21. Tumour Biol. 2013. PMID: 23784459

4

Is there any diagnostic value of serum protease-activated receptor-1 (PAR1) levels on determination of epithelial ovarian carcinoma?

Karabulut S, Akşit E, Tas F, Ciftci R, Aydiner A, Yildiz I, Keskin S, Eralp Y, Yasasever CT, Vatansever S, Disci R, Saip P. Karabulut S, et al. Tumour Biol. 2014 May;35(5):4323-9. doi: 10.1007/s13277-013-1567-4. Epub 2014 Jan 5. Tumour Biol. 2014. PMID: 24390664

5

Serum levels of LDH, CEA, and CA19-9 have prognostic roles on survival in patients with metastatic pancreatic cancer receiving gemcitabine-based chemotherapy.

Tas F, Karabulut S, Ciftci R, Sen F, Sakar B, Disci R, Duranyildiz D. Tas F, et al. Among authors: karabulut s. Cancer Chemother Pharmacol. 2014 Jun;73(6):1163-71. doi: 10.1007/s00280-014-2450-8. Epub 2014 Mar 20. Cancer Chemother Pharmacol. 2014. PMID: 24647734

6

Clinical significance of serum tenascin-C levels in breast cancer.

Tastekin D, Tas F, Karabulut S, Duranyildiz D, Serilmez M, Guveli M, Vatansever S. Tastekin D, et al. Among authors: karabulut s. Tumour Biol. 2014 Jul;35(7):6619-25. doi: 10.1007/s13277-014-1875-3. Epub 2014 Apr 3. Tumour Biol. 2014. PMID: 24696262

7

The diagnostic, predictive, and prognostic role of serum epithelial cell adhesion molecule (EpCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in breast cancer.

Karabulut S, Tas F, Tastekin D, Karabulut M, Yasasever CT, Ciftci R, Güveli M, Fayda M, Vatansever S, Serilmez M, Disci R, Aydıner A. Karabulut S, et al. Among authors: karabulut m. Tumour Biol. 2014 Sep;35(9):8849-60. doi: 10.1007/s13277-014-2151-2. Epub 2014 Jun 3. Tumour Biol. 2014. PMID: 24891186

8

Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in patients with breast cancer.

Tas F, Karabulut S, Bilgin E, Tastekin D, Duranyildiz D. Tas F, et al. Among authors: karabulut s. Tumour Biol. 2014 Sep;35(9):9303-9. doi: 10.1007/s13277-014-2224-2. Epub 2014 Jun 19. Tumour Biol. 2014. PMID: 24943688

9

Clinical significance of serum fibronectin and vitronectin levels in melanoma patients.

Tas F, Karabulut S, Bilgin E, Tastekin D, Duranyildiz D. Tas F, et al. Among authors: karabulut s. Melanoma Res. 2014 Oct;24(5):475-9. doi: 10.1097/CMR.0000000000000107. Melanoma Res. 2014. PMID: 24999757

10

Serum transforming growth factor-beta1 levels may have predictive and prognostic roles in patients with gastric cancer.

Tas F, Yasasever CT, Karabulut S, Tastekin D, Duranyildiz D. Tas F, et al. Among authors: karabulut s. Tumour Biol. 2015 Mar;36(3):2097-103. doi: 10.1007/s13277-014-2817-9. Epub 2014 Nov 13. Tumour Biol. 2015. PMID: 25391430

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195 results

Search Page

Filters